Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
doi: 10.2169/internalmedicine.49.3401
GLP-1 agonistlerinin kilo kayb zerindeki etkileri oklu mekanizmalar zerinden gereklemektedir
Recent studies are investigating its use in the treatment of obesity, non-alcoholic steatohepatitis (NASH), and even Alzheimers disease, suggesting that the impact of this drug could reach well beyond its current applications
Real quality
Funding This study was supported by a grant from the National Natural Science Foundation of China (No
Lastly, we were unable to conduct a proper as-treated analysis due to the limitations of the analytical platform, which precluded accurate accounting for treatment adherence and duration
US$ 22.69
US$ 27.36
US$ 20.12
